AdvanCell to participate in Jefferies Global Healthcare Conference in London

AdvanCell to share positive 212Pb-ADVC001 results and US expansion updates at the Jefferies Global Healthcare Conference in London (17–20 Nov 2025).

Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months

BOSTON & MONTREAL, November 11, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, non ...